Heterogeneity of Clinical N1 Non-Small Cell Lung Cancer

Abstract

Introduction There have been many reports of N1 node metastasis on computed tomography (CT) scan, but not on positron emission tomography (PET)-CT in nonsmall cell lung cancer. The aim of this study was to analyze the clinicopathologic correlation and survival of N1 disease on preoperative PET-CT.

Methods From January 2003 to December 2007, 1,748 curative lung resections were performed at a single institute. We enrolled 91 patients with clinical N1 on PET-CT. All the enrolled patients had undergone pulmonary resection with mediastinal lymph node dissection. According to the preoperative PET-CT, we classified the patients into two groups: those with single N1 metastasis (cN1a, n = 91) and those with multiple N1 metastases (cN1b, n = 8). Clinicopathologic N staging was compared and survival analysis was performed.

Results Pathologic N2 was found in 19 (19%) patients and was more common in cN1b (4 of 8) than in cN1a group (15 of 91) (p = 0.042). Overall or disease-free survival rate was not different between cN1a and cN1b in the pathologic non-N2 (p = 0.723, 0.905) or in pathologic N2 (p = 0.954, 0.607) subgroups.

Conclusion Clinical N1 on PET-CT is heterogeneous in its pathologic staging and multiple clinical N1 is more related to pathologic N2 than single clinical N1. More cases are needed to show the prognostic significance of multiple clinical N1-pathologic N2.

Keywords

lung cancer - diagnosis (includes staging, imaging, and fiducial) - lung cancer treatment (surgery and medicine) - positron emission tomography

• References

• 1 Beyer T, Townsend DW, Brun T , et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41 (8) 1369-1379
• 2 von Schulthess GK. Cost considerations regarding an integrated CT-PET system. Eur Radiol 2000; 10 (Suppl. 03) S377-S380
• 3 Billé A, Pelosi E, Skanjeti A , et al. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg 2009; 36 (3) 440-445
• 4 Lee BE, Redwine J, Foster C , et al. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3. J Thorac Cardiovasc Surg 2008; 135 (3) 615-619
• 5 Halter G, Buck AK, Schirrmeister H , et al. Lymph node staging in lung cancer using [18F]FDG-PET. Thorac Cardiovasc Surg 2004; 52 (2) 96-101
• 6 Subedi N, Scarsbrook A, Darby M, Korde K, Mc Shane P, Muers MF. The clinical impact of integrated FDG PET-CT on management decisions in patients with lung cancer. Lung Cancer 2009; 64 (3) 301-307
• 7 Fischer B, Lassen U, Mortensen J , et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 2009; 361 (1) 32-39
• 8 Nakagawa M, Hara M, Sakurai K , et al. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer. Acta Radiol 2009; 50 (6) 638-644
• 9 Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111 (6) 1718-1723
• 10 Yi CA, Lee KS, Kim BT , et al. Efficacy of helical dynamic CT versus integrated PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer. AJR Am J Roentgenol 2007; 188 (2) 318-325
• 11 Rusch VW, Crowley J, Giroux DJ , et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2: 603-612
• 12 Caldarella A, Crocetti E, Comin CE, Janni A, Pegna AL, Paci E. Prognostic variability among nonsmall cell lung cancer patients with pathologic N1 lymph node involvement. Epidemiological figures with strong clinical implications. Cancer 2006; 107 (4) 793-798
• 13 Demir A, Turna A, Kocaturk C , et al. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer. Ann Thorac Surg 2009; 87 (4) 1014-1022
• 14 Sayar A, Turna A, Kiliçgün A, Solak O, Urer N, Gürses A. Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung. Eur J Cardiothorac Surg 2004; 25 (3) 434-438
• 15 Berghmans T, Dusart M, Paesmans M , et al; European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 2008; 3 (1) 6-12
• 16 Kramer H, Post WJ, Pruim J, Groen HJ. The prognostic value of positron emission tomography in non-small cell lung cancer: analysis of 266 cases. Lung Cancer 2006; 52 (2) 213-217